Marshall Wace, LLP Chimerix Inc Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Chimerix Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 156,076 shares of CMRX stock, worth $521,293. This represents 0.0% of its overall portfolio holdings.
Number of Shares
156,076
Previous 156,076
-0.0%
Holding current value
$521,293
Previous $137,000
5.84%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CMRX
# of Institutions
70Shares Held
37MCall Options Held
52.7KPut Options Held
130K-
Ra Capital Management, L.P. Boston, MA8.8MShares$29.4 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$14.5 Million0.0% of portfolio
-
Monaco Asset Management Sam4.22MShares$14.1 Million0.58% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.4MShares$8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.21MShares$7.37 Million0.03% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $293M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...